Less Ads, More Data, More Tools Register for FREE

Pin to quick picksENRC.L Regulatory News (ENRC)

  • There is currently no data for ENRC

Form 8.5 (EPT/NON-RI) - ENRC

24 May 2013 10:37

RNS Number : 5368F
Societe Generale SA
24 May 2013
 



FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

SOCIETE GENERALE SA

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Eurasian Natural Resources Corp Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mr. Alexander Machkevitch, Mr. Alijan Ibragimov, Mr. Patokh Chodiev and the Kazakh Government

(d) Date position held/dealing undertaken:

23/05/2013

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES: Kazakhmys Plc

 

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

USD 0.20 Ordinary share

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

658,008

0.05

77,006

0.01

(2) Derivatives (other than options):

0

0.00

2,000

0.00

(3) Options and agreements to purchase/sell:

0

 

0.00

0

 

0.00

TOTAL:

658,008

0.05

79,006

0.01

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

(GBP)

Ordinary share

Purchase

376

2.5690

Ordinary share

Purchase

438

2.5950

Ordinary share

Purchase

687

2.5960

Ordinary share

Purchase

983

2.6570

Ordinary share

Purchase

1,204

2.5900

Ordinary share

Purchase

5,090

2.6550

Ordinary share

Purchase

809

2.5950

Ordinary share

Purchase

104

2.5690

Ordinary share

Purchase

2,683

2.6660

Ordinary share

Purchase

100

2.6530

Ordinary share

Purchase

2,366

2.6320

Ordinary share

Purchase

1,533

2.6350

Ordinary share

Purchase

2,363

2.6350

Ordinary share

Purchase

322

2.6600

Ordinary share

Purchase

871

2.6270

Ordinary share

Purchase

1,628

2.6530

Ordinary share

Purchase

349

2.6630

Ordinary share

Purchase

1,635

2.6680

Ordinary share

Purchase

2,380

2.6350

Ordinary share

Purchase

454

2.6270

Ordinary share

Purchase

900

2.6250

Ordinary share

Purchase

1,313

2.6290

Ordinary share

Purchase

617

2.5840

Ordinary share

Purchase

1,564

2.6490

Ordinary share

Purchase

528

2.5840

Ordinary share

Purchase

2,435

2.6080

Ordinary share

Purchase

2,476

2.6350

Ordinary share

Purchase

906

2.6480

Ordinary share

Purchase

1,035

2.5770

Ordinary share

Purchase

215

2.6200

Ordinary share

Purchase

900

2.6480

Ordinary share

Purchase

914

2.6490

Ordinary share

Purchase

936

2.6280

Ordinary share

Purchase

1,081

2.6530

Ordinary share

Purchase

242

2.6150

Ordinary share

Purchase

2,261

2.6530

Ordinary share

Purchase

993

2.6350

Ordinary share

Purchase

949

2.6280

Ordinary share

Purchase

869

2.6680

Ordinary share

Purchase

951

2.6600

Ordinary share

Purchase

823

2.5960

Ordinary share

Purchase

100

2.5770

Ordinary share

Purchase

1,709

2.5710

Ordinary share

Purchase

2,447

2.6080

Ordinary share

Purchase

2,406

2.6080

Ordinary share

Purchase

1,866

2.6240

Ordinary share

Purchase

2,278

2.6080

Ordinary share

Purchase

776

2.6570

Ordinary share

Purchase

1,681

2.6600

Ordinary share

Purchase

129

2.6270

Ordinary share

Purchase

1,436

2.6660

Ordinary share

Purchase

1,210

2.5900

Ordinary share

Sale

583

2.6600

Ordinary share

Sale

708

2.6600

Ordinary share

Sale

148

2.5840

Ordinary share

Sale

59

2.5780

Ordinary share

Sale

1

2.5880

Ordinary share

Sale

5

2.6260

Ordinary share

Sale

2,380

2.5700

Ordinary share

Sale

852

2.6260

Ordinary share

Sale

1,381

2.6100

Ordinary share

Sale

1,654

2.6680

Ordinary share

Sale

164

2.6600

Ordinary share

Sale

556

2.6380

Ordinary share

Sale

4

2.6680

Ordinary share

Sale

905

2.6530

Ordinary share

Sale

1,149

2.5890

Ordinary share

Sale

1,138

2.6480

Ordinary share

Sale

1,232

2.6460

Ordinary share

Sale

669

2.6270

Ordinary share

Sale

938

2.6470

Ordinary share

Sale

1,395

2.6550

Ordinary share

Sale

3,254

2.6500

Ordinary share

Sale

1,290

2.6450

Ordinary share

Sale

106

2.6110

Ordinary share

Sale

47

2.5730

Ordinary share

Sale

357

2.6000

Ordinary share

Sale

1,018

2.6490

Ordinary share

Sale

1,814

2.6600

Ordinary share

Sale

1,000

2.6630

Ordinary share

Sale

1,700

2.6680

Ordinary share

Sale

2,651

2.6550

Ordinary share

Sale

979

2.6660

Ordinary share

Sale

2,427

2.6100

Ordinary share

Sale

29

2.5870

Ordinary share

Sale

479

2.5850

Ordinary share

Sale

700

2.5980

Ordinary share

Sale

94

2.5850

Ordinary share

Sale

488

2.6270

Ordinary share

Sale

1,447

2.6440

Ordinary share

Sale

7,799

2.6620

Ordinary share

Sale

800

2.6000

Ordinary share

Sale

914

2.6490

Ordinary share

Sale

2,516

2.6100

Ordinary share

Sale

453

2.6330

Ordinary share

Sale

854

2.5980

Ordinary share

Sale

995

2.6450

Ordinary share

Sale

970

2.6440

Ordinary share

Sale

1,442

2.6660

Ordinary share

Sale

570

2.6100

Ordinary share

Sale

823

2.6600

Ordinary share

Sale

1,355

2.5880

Ordinary share

Sale

1,451

2.5880

Ordinary share

Sale

897

2.5700

Ordinary share

Sale

1,196

2.6450

Ordinary share

Sale

443

2.5830

Ordinary share

Sale

224

2.6330

Ordinary share

Sale

29

2.5610

Ordinary share

Sale

480

2.6550

Ordinary share

Sale

1,270

2.6440

Ordinary share

Sale

59

2.6510

Ordinary share

Sale

1,747

2.6000

Ordinary share

Sale

1,387

2.6240

Ordinary share

Sale

1,115

2.6500

Ordinary share

Sale

805

2.5910

Ordinary share

Sale

982

2.6100

Ordinary share

Sale

4,488

2.6550

Ordinary share

Sale

492

2.6270

Ordinary share

Sale

1,014

2.6450

Ordinary share

Sale

2,526

2.5700

Ordinary share

Sale

800

2.6330

Ordinary share

Sale

1,276

2.6460

Ordinary share

Sale

1,442

2.6330

Ordinary share

Sale

1,041

2.6630

Ordinary share

Sale

689

2.6270

Ordinary share

Sale

839

2.5910

Ordinary share

Sale

1,442

2.6530

Ordinary share

Sale

522

2.5970

Ordinary share

Sale

553

2.6380

Ordinary share

Sale

666

2.5900

Ordinary share

Sale

1,702

2.6000

Ordinary share

Sale

348,796

2.8670

Ordinary share

Sale

192

2.6550

Ordinary share

Sale

219

2.6100

Ordinary share

Sale

995

2.6360

Ordinary share

Sale

482

2.6460

Ordinary share

Sale

58

2.6630

Ordinary share

Sale

485

2.5980

Ordinary share

Sale

2,311

2.6450

Ordinary share

Sale

170

2.6680

Ordinary share

Sale

389

2.6530

Ordinary share

Sale

892

2.6380

Ordinary share

Sale

1,776

2.6620

Ordinary share

Sale

1,600

2.6100

Ordinary share

Sale

958

2.6560

Ordinary share

Sale

309

2.6380

Ordinary share

Sale

29

2.6270

Ordinary share

Sale

355

2.5900

Ordinary share

Sale

994

2.6470

Total purchases

65,321

Total sales

447,879

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit (GBP)

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

 

 

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

24/05/2013

Contact name:

Benoît Champion

Telephone number:

+44 20 7676 6280

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOFMGZKLDVGFZG
Date   Source Headline
22nd Apr 20139:30 amRNSForm 8.5 (EPT/RI) ENRC PLC
22nd Apr 20139:29 amRNSForm 8.5 (EPT/RI) ENRC PLC
19th Apr 20134:33 pmRNSResponse to Announcement
19th Apr 20131:50 pmRNSrecent press speculation
11th Apr 20133:30 pmRNSDirectorate Change
20th Mar 20137:00 amRNSFinal Results
27th Feb 201311:30 amRNSUpdate on Effective Tax Rate and Annual Impairment
6th Feb 20137:00 amRNSQ4 Production Report
28th Dec 20124:15 pmRNSCompletion of Acquisition
28th Dec 201211:00 amRNSResult of EGM
10th Dec 20124:21 pmRNSCirc re. Camrose acquisition
10th Dec 20127:00 amRNSAcquisition
23rd Nov 20127:00 amRNSBoard and Senior Management Changes
8th Nov 20127:00 amRNSQ3 Production Report and IMS
1st Oct 201211:06 amRNSPostponement of Proposed Copper Seminar
15th Aug 20127:00 amRNSHalf Yearly Report
10th Aug 20124:15 pmRNSChanges to Board Committees
1st Aug 20127:00 amRNSQ2 Production Report
31st Jul 20127:00 amRNSAcquisition of Frontier Licence
12th Jun 20123:15 pmRNSResult of AGM
29th May 20124:40 pmRNS2011 Sustainable Development Report
25th May 201212:36 pmRNSDirectorate Change
11th May 20125:39 pmRNSAnnual Information Update
10th May 20127:00 amRNSInterim Management Statement
8th May 20127:00 amRNSStatement re Press Speculation
4th May 20127:00 amRNSDirector/PDMR Shareholding
4th May 20127:00 amRNSDirector/PDMR Shareholding
4th May 20127:00 amRNSDirector/PDMR Shareholding
26th Apr 20125:12 pmRNSAnnual Financial Report
17th Apr 20127:00 amRNSCompletion of Shubarkol Acquisition
2nd Apr 20121:23 pmRNSResult of EGM
21st Mar 20126:04 pmRNSCirc re. reconvening of General Meeting
21st Mar 20127:00 amRNSFinal Results
21st Mar 20127:00 amRNSReconvening of General Meeting
2nd Mar 20121:30 pmRNSClosure of Previously Announced Transaction
2nd Mar 20121:30 pmRNSCompletion of Acquisition
28th Feb 201212:30 pmRNSLoan Facility
21st Feb 20122:45 pmRNSMMK Contract Update
3rd Feb 20122:33 pmRNSBoard Changes
1st Feb 20127:00 amRNSQ4 Production Report
5th Jan 201212:34 pmRNSFIRST QUANTUM REACHES AGREEMENT WITH ENRC
5th Jan 201212:28 pmRNSConference Call re Acquisition
5th Jan 201212:27 pmRNSAcquisition and Legal Settlement
14th Dec 20115:13 pmRNSDirector Declaration
5th Dec 20111:01 pmRNSENRC and MMK settled legal claims
10th Nov 20117:00 amRNSQ3 Production Report and IMS
7th Nov 20114:18 pmRNSResult of EGM
4th Nov 20113:30 pmRNSAdjournment of General Meeting
11th Oct 20115:30 pmRNSCirc re. Proposed Exercise of Option
11th Oct 201112:30 pmRNSSite Visits for Analysts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.